Michael Johnsrud

1.6k total citations
40 papers, 1.2k citations indexed

About

Michael Johnsrud is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Family Practice. According to data from OpenAlex, Michael Johnsrud has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 15 papers in Psychiatry and Mental health and 12 papers in Family Practice. Recurrent topics in Michael Johnsrud's work include Schizophrenia research and treatment (13 papers), Medication Adherence and Compliance (12 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Michael Johnsrud is often cited by papers focused on Schizophrenia research and treatment (13 papers), Medication Adherence and Compliance (12 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Michael Johnsrud collaborates with scholars based in United States, Switzerland and Canada. Michael Johnsrud's co-authors include M. Lynn Crismon, Nick C. Patel, Kenneth A. Lawson, Karen L. Rascati, Lee Schwartzberg, Jamie C. Barner, Edward Drozd, Robert A. Rosenheck, Scott W. Woods and C. Bruce Baker and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The British Journal of Psychiatry.

In The Last Decade

Michael Johnsrud

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Johnsrud United States	18	385	319	237	203	164	40	1.2k
Gabriel Sanfélix‐Gimeno Spain	24	271 0.7×	217 0.7×	127 0.5×	279 1.4×	61 0.4×	92	1.6k
Jeanne M. Madden United States	23	260 0.7×	521 1.6×	310 1.3×	365 1.8×	195 1.2×	43	1.6k
Anna Birna Almarsdóttir Denmark	19	204 0.5×	309 1.0×	331 1.4×	177 0.9×	94 0.6×	79	1.5k
J Cooper United Kingdom	23	204 0.5×	322 1.0×	229 1.0×	196 1.0×	511 3.1×	41	1.6k
Rhian Parham United Kingdom	9	361 0.9×	154 0.5×	243 1.0×	605 3.0×	139 0.8×	11	1.4k
Jaana E. Martikainen Finland	19	263 0.7×	319 1.0×	273 1.2×	107 0.5×	97 0.6×	44	1.3k
Pamela C. Heaton United States	23	137 0.4×	147 0.5×	144 0.6×	151 0.7×	44 0.3×	83	1.4k
Kevin C. Farmer United States	16	255 0.7×	197 0.6×	269 1.1×	590 2.9×	62 0.4×	33	1.5k
Olivier Bugnon Switzerland	21	195 0.5×	196 0.6×	218 0.9×	488 2.4×	30 0.2×	97	1.4k
Lalitha Raman‐Wilms Canada	18	197 0.5×	241 0.8×	227 1.0×	97 0.5×	59 0.4×	39	1.2k

Countries citing papers authored by Michael Johnsrud

Since Specialization

Citations

This map shows the geographic impact of Michael Johnsrud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Johnsrud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Johnsrud more than expected).

Fields of papers citing papers by Michael Johnsrud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Johnsrud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Johnsrud. The network helps show where Michael Johnsrud may publish in the future.

Co-authorship network of co-authors of Michael Johnsrud

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Johnsrud. A scholar is included among the top collaborators of Michael Johnsrud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Johnsrud. Michael Johnsrud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnsrud, Michael, et al.. (2024). Detailing Healthcare Claims Data Evidence of Extrapyramidal Symptoms in Medicaid Patients with Schizophrenia after Second-Generation Antipsychotic Medication Initiation. Community Mental Health Journal. 61(3). 432–439. 1 indexed citations

Mantri, Sneha, et al.. (2024). A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups. Patient Preference and Adherence. Volume 18. 1919–1928. 2 indexed citations

Johnsrud, Michael, et al.. (2024). Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia. Patient Preference and Adherence. Volume 18. 177–185. 2 indexed citations

Johnsrud, Michael, et al.. (2023). One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication. Administration and Policy in Mental Health and Mental Health Services Research. 51(2). 207–216. 2 indexed citations

Sollano, Jose D., et al.. (2019). PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA. Value in Health. 22. S514–S514.

Schmitt, Steven, Daniel P. McQuillen, Ronald Nahass, et al.. (2013). Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs. Clinical Infectious Diseases. 58(1). 22–28. 141 indexed citations

Lawson, Kenneth A., Michael Johnsrud, Paul Hodgkins, Rahul Sasané, & M. Lynn Crismon. (2012). Utilization Patterns of Stimulants in ADHD in the Medicaid Population: A Retrospective Analysis of Data from the Texas Medicaid Program. Clinical Therapeutics. 34(4). 944–956.e4. 38 indexed citations

Moczygemba, Leticia R., Jamie C. Barner, Kenneth A. Lawson, et al.. (2011). Impact of Telephone Medication Therapy Management on Medication and Health-Related Problems, Medication Adherence, and Medicare Part D Drug Costs: A 6-Month Follow Up. The American journal of geriatric pharmacotherapy. 9(5). 328–338. 37 indexed citations

Moczygemba, Leticia R., Jamie C. Barner, Carolyn M. Brown, et al.. (2010). Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Research in Social and Administrative Pharmacy. 6(2). 143–154. 41 indexed citations

10.

Panjabi, Sumeet, et al.. (2008). Extended-Release, Once-Daily Morphine (Avinza) for the Treatment of Chronic Nonmalignant Pain: Effect on Pain, Depressive Symptoms, and Cognition. Pain Medicine. 9(8). 985–993. 17 indexed citations

11.

Rascati, Karen L., Manabu Akazawa, Michael Johnsrud, Richard H. Stanford, & Christopher M. Blanchette. (2007). Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clinical Therapeutics. 29(6). 1203–1213. 20 indexed citations

12.

Poston, Sara, Michael Dickson, Michael Johnsrud, et al.. (2007). Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing. Clinical Therapeutics. 29(3). 504–518. 8 indexed citations

13.

Patel, Nick C., M. Lynn Crismon, Alexander L. Miller, & Michael Johnsrud. (2005). Drug Adherence: Effects of Decreased Visit Frequency on Adherence to Clozapine Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(9). 1242–1247. 39 indexed citations

14.

Johnsrud, Michael, M. Lynn Crismon, Ann Thompson, & Amy Grogg. (2005). An Economic Comparison of Risperidone and Olanzapine Use within an Integrated Managed Mental Health Program. Administration and Policy in Mental Health and Mental Health Services Research. 33(2). 237–243.

15.

Patel, Nick C., M. Lynn Crismon, Kimberly Hoagwood, et al.. (2005). Physician Specialty Associated With Antipsychotic Prescribing for Youths in the Texas Medicaid Program. Medical Care. 44(1). 87–90. 11 indexed citations

16.

Baker, C. Bruce, Michael Johnsrud, M. Lynn Crismon, Robert A. Rosenheck, & Scott W. Woods. (2003). Quantitative analysis of sponsorship bias in economic studies of antidepressants. The British Journal of Psychiatry. 183(6). 498–506. 109 indexed citations

17.

Frei, Christopher R., Jim M. Koeller, David S. Burgess, Robert L. Talbert, & Michael Johnsrud. (2003). Impact of Atypical Coverage for Patients with Community‐Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community‐Acquired Pneumonia Project. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(9). 1167–1174. 22 indexed citations

18.

Rascati, Karen L., et al.. (2003). Ethnic Differences in Use of Antipsychotic Medication Among Texas Medicaid Clients With Schizophrenia. The Journal of Clinical Psychiatry. 64(6). 635–639. 17 indexed citations

19.

Rascati, Karen L., Michael Johnsrud, M. Lynn Crismon, Maureen J. Lage, & Beth Barber. (2003). Olanzapine versus Risperidone in the Treatment of Schizophrenia. PharmacoEconomics. 21(10). 683–697. 45 indexed citations

20.

Patel, Nick C., Robert J. Sanchez, Michael Johnsrud, & M. Lynn Crismon. (2002). Trends in Antipsychotic Use in a Texas Medicaid Population of Children and Adolescents: 1996 to 2000. Journal of Child and Adolescent Psychopharmacology. 12(3). 221–229. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact